June 27 : The FDA approved UCBs Rystiggo (rozanolixizumab), a subcutaneously administered humanized IgG4 monoclonal antibody, to treat generalized myasthenia gravis, a rare muscle-wasting autoimmune disease
Along the way, we celebrate your personal wins, both big and small
We will cover the specific benefits for bone health, the relationship between Vitamin D and autoimmune responses, and the importance of choosing a highly bioavailable delivery methodtopics that also align with our Healthy Aging Supplements collection
Gip, L., Lodin, A
Most people with rosacea also experience episodes of more intense redness or flushing related to specific triggers (eg, exposure to sunlight or eating spicy food)
Ozempic and Iron Deficiency: An Indirect Connection Research published in 2025 provides compelling evidence that semaglutide and iron deficiency may be connected through indirect mechanisms affecting nutrient absorption